Change Control Evaluation and Submission Strategy

Freyr offers comprehensive change control evaluation and submission strategy services for pharmaceutical products in Canada. Our expertise covers impact assessment, strategy development, and documentation preparation to ensure Regulatory compliance and efficient management of post-approval changes.

Change Control Evaluation and Submission Strategy - Overview

A strong Submission Strategy is crucial for managing changes that impact the approved content of the application. Such changes necessitate a comprehensive assessment to ascertain the most suitable course of action. In the pharmaceutical sector, the change control process and the assessment of the impact on ANDS/DIN/DMF should encompass a deep comprehension of the alteration, visibility into all affected products (including finished products and APIs), and the identification of all countries where these products are registered. Additionally, this process might extend to countries where a new product submission or approval is pending.

As the registered details for a product can differ between countries, it is essential to review all the amendments of relevant information so that a complete change control impact assessment can be performed, considering the regulations and guidelines applicable in the intended country (i.e., Canada), where the product is approved. The assessment will determine the classification of the change and the required supporting documentation.

A robust change control assessment of the product is critical in developing a suitable ANDS/DIN/MF change submission strategy and ensuring continued product compliance. Freyr’s Regulatory affairs team, with domain knowledge of research, manufacturing, quality, change control evaluation/assessment, post-approval submission strategy, and preparation of change-related submission packages in alignment with Health Authority requirements and guidelines, can support in your end-to-end pharma change control activities.

Change Control Evaluation and Submission Strategy - Expertise

  • Evaluation of change control and supporting documents in line with HC post-approval submission guidelines
  • Preparation of a post-approval submission strategy for the proposed change
  • Providing the list of supporting documents/data to be included/generated
  • Guidance on the implementation strategy for the proposed change
  • Preparation of supporting Regulatory documentation (e.g., revised Module 3 sections, Module 1 documentation) for finished products and APIs.
Change Control Evaluation and Submission Strategy

Celebrating Customers Success

 

Medicinal Products

Regulatory Affairs

India

Thank you for the timely support over the weekend, which allowed us to resubmit quickly after being notified. This continuously demonstrates Freyr's commitment towards our company’s milestones.

Director - Global Regulatory Affairs – Operations

India-based, Global Top Generic Pharma Company

 

Medicinal Products

Publishing

UK

I am sure you have heard by now that we have received our first-ever approval from the FDA for our Brands division. This is a major milestone for us as well as for my team here in Reg Ops. I would be remiss if I didn’t point out that we would not have been able to do this without the help of your dedicated team. From the original filing, then the following year of responses, all helped get us to final approval.

Thank you Freyr team for a job well done!

Sr. Director, Head of Regulatory Operations

Ireland-based, Global Specialty Pharmaceutical Company

 

Medicinal Products

Regulatory Affairs

USA

Please relate to the team the excellent job they have done on the IND reactivation. Specifically, the high-quality module 3, written by Freyr. It was very comprehensive, very few revisions were required, and we had no questions from Health Canada or FDA. No CMC questions: that was a first for me. So very responsive to my many requests, which I am sure can be frustrating but always helpful while producing excellent work.

Thank you for always being available and responding quickly and comprehensively to all my requests.

What a great team you have, Freyr.

Lynne McGrath

Regulatory Consultant

 

Medicinal Products

Regulatory Affairs

USA

Congratulations!!! ​

Thanks for your great support for a successful ANDA filing, especially to the publishing team. Heartfully appreciate their last hours of hard work.

Assistant Manager​

US-based, Leading, Complex Generic Pharmaceutical Products Company​

 

Medicinal Products

Regulatory Affairs

USA

Thank you all for the great support!​

CEO

US-based, Leading Innovative Pharmaceuticals Company​

 

Medicinal Products

Regulatory Affairs

USA

The ANDA receipt has been received! Thank you very much for your hard work, patience, and support for our work over the last couple of months. We are delighted that we were able to meet the timeline and hit an important corporate goal of our young company. ​

Thank you again, and we look forward to working with your team on the next project!

Senior Director of Business and Product Development​

US-based, Leading Innovator Pharmaceuticals Company​